FdaApplication
NDA 020740
Identifiers
- fda_app_no: NDA020740
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1997-06-26 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BAYCOL | CERIVASTATIN SODIUM | 0.1MG | TABLET;ORAL |
| BAYCOL | CERIVASTATIN SODIUM | 0.8MG | TABLET;ORAL |
| BAYCOL | CERIVASTATIN SODIUM | 0.2MG | TABLET;ORAL |
| BAYCOL | CERIVASTATIN SODIUM | 0.05MG | TABLET;ORAL |
| BAYCOL | CERIVASTATIN SODIUM | 0.4MG | TABLET;ORAL |
| BAYCOL | CERIVASTATIN SODIUM | 0.3MG | TABLET;ORAL |
6 products